NAPLEX (North American Pharmacist Licensure Examination) Practice Exam 2026 - Free NAPLEX Practice Questions and Study Guide

Session length

1 / 20

Esketamine (Spravato) is indicated for:

Common cold symptoms

Epilepsy

Treatment-resistant depression and depression with suicidality

Esketamine (Spravato) is indicated for the treatment of treatment-resistant depression and depression with suicidality. It is a nasal spray medication that acts as a glutamate receptor modulator. This medication is specifically approved for patients who have not found relief with other antidepressant treatments. Options A, B, and D are incorrect because Esketamine is not indicated for the treatment of common cold symptoms, epilepsy, or migraine headaches.

Get further explanation with Examzify DeepDiveBeta

Migraine headaches

Next Question
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy